Additionally, CMLD-2, a disruptor of interaction between HuR and mRNA targets, exerts antitumor effects in thyroid cancer cells by decreasing cell viability and increasing apoptosis [50], highlighting HuR as a promising therapeutic target for cancers. This evidence concerns the gene ELAVL1 and cancer.